HCA Healthcare, Inc. SEC filings HCA

HCA Healthcare, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Feb 12, 2018. Its latest annual report, Form ARS, was filed on Mar 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (material agreement, new debt, other events). The company's fiscal year ends on December 31.

HCA Healthcare, Inc. SEC filings
Form Description Filed Period
8-K Current report
Material agreement, New debt, Other events
Nov 5, 2026 Nov 2, 2026
144 Notice of proposed sale Nov 4, 2026 —
144 Notice of proposed sale Nov 4, 2026 —
424B5 Prospectus supplement Nov 4, 2026 —
4 Insider transaction Nov 3, 2026 Oct 30, 2026
FWP Free writing prospectus Nov 3, 2026 —
4 Insider transaction Nov 2, 2026 Oct 29, 2026
8-K Current report
Other events
Nov 2, 2026 Nov 2, 2026
424B3 Prospectus Nov 2, 2026 —
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
144 Notice of proposed sale Oct 29, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Oct 27, 2026 Oct 27, 2026
3 Initial insider ownership Sep 11, 2026 Sep 1, 2026
4 Insider transaction Aug 28, 2026 Aug 26, 2026
8-K Current report
New debt, Other events
Jul 29, 2026 Jul 29, 2026
10-Q Quarterly report Jul 28, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jul 24, 2026 Jul 24, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jul 14, 2026 Jul 14, 2026
8-K Current report
Officer or director change
Jun 18, 2026 Jun 15, 2026
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
4 Insider transaction Apr 30, 2026 Apr 28, 2026
8-K Current report
Material agreement, New debt, Other events
Apr 30, 2026 Apr 27, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
424B5 Prospectus supplement Apr 29, 2026 —
10-Q Quarterly report Apr 29, 2026 Mar 31, 2026
8-K Current report
Shareholder vote results
Apr 28, 2026 Apr 23, 2026
FWP Free writing prospectus Apr 28, 2026 —
8-K Current report
Other events
Apr 27, 2026 Apr 27, 2026
424B3 Prospectus Apr 27, 2026 —
S-3ASR Automatic shelf registration Apr 27, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Apr 24, 2026 Apr 24, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
ARS Annual report to shareholders Mar 13, 2026 Dec 31, 2025
DEFA14A Additional proxy material Mar 13, 2026 —
DEF 14A Proxy statement Mar 13, 2026 Apr 23, 2026
8-K Current report
Officer or director change
Feb 25, 2026 Feb 20, 2026
4 Insider transaction Feb 18, 2026 Feb 13, 2026
144 Notice of proposed sale Feb 18, 2026 —
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Feb 12, 2026 Feb 10, 2026
144 Notice of proposed sale Feb 11, 2026 —
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
SCHEDULE 13D Ownership over 5% (active) Feb 10, 2026 —
10-K Annual report Feb 10, 2026 Dec 31, 2025
4 Insider transaction Feb 9, 2026 Feb 5, 2026
4 Insider transaction Feb 9, 2026 Feb 5, 2026
3 Initial insider ownership Feb 6, 2026 Feb 1, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
144 Notice of proposed sale Feb 3, 2026 —
144 Notice of proposed sale Feb 3, 2026 —
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
4 Insider transaction Feb 2, 2026 Jan 29, 2026
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jan 27, 2026 Jan 27, 2026
4 Insider transaction Nov 18, 2025 Nov 14, 2025
4 Insider transaction Nov 5, 2025 Nov 3, 2025
4 Insider transaction Nov 5, 2025 Nov 3, 2025
144 Notice of proposed sale Nov 5, 2025 —
4 Insider transaction Nov 4, 2025 Oct 31, 2025
8-K Current report
Material agreement, New debt, Other events
Oct 31, 2025 Oct 27, 2025
10-Q Quarterly report Oct 30, 2025 Sep 30, 2025
424B5 Prospectus supplement Oct 29, 2025 —
FWP Free writing prospectus Oct 27, 2025 —
8-K Current report
Other events
Oct 27, 2025 Oct 27, 2025
424B3 Prospectus Oct 27, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Oct 24, 2025 Oct 24, 2025
144 Notice of proposed sale Sep 8, 2025 —
4 Insider transaction Sep 8, 2025 Sep 4, 2025
10-Q Quarterly report Aug 4, 2025 Jun 30, 2025
4 Insider transaction Jul 31, 2025 Jul 29, 2025
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jul 25, 2025 Jul 25, 2025
3 Initial insider ownership Jul 18, 2025 Jul 15, 2025
8-K Current report
Officer or director change
Jul 11, 2025 Jul 8, 2025
S-8 Employee stock plan registration Jun 23, 2025 —
8-K Current report
New debt, Other events
Jun 10, 2025 Jun 10, 2025
4 Insider transaction May 15, 2025 May 13, 2025
4 Insider transaction May 15, 2025 May 13, 2025
144 Notice of proposed sale May 13, 2025 —
4 Insider transaction May 8, 2025 May 6, 2025
4 Insider transaction May 1, 2025 Apr 29, 2025
4 Insider transaction May 1, 2025 Apr 29, 2025
4 Insider transaction May 1, 2025 Apr 29, 2025
4 Insider transaction May 1, 2025 Apr 29, 2025
4 Insider transaction May 1, 2025 Apr 29, 2025
4 Insider transaction May 1, 2025 Apr 29, 2025
4 Insider transaction May 1, 2025 Apr 29, 2025
4 Insider transaction May 1, 2025 Apr 29, 2025
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Apr 29, 2025 Apr 24, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 25, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Apr 25, 2025 Apr 25, 2025
4 Insider transaction Mar 28, 2025 Jul 26, 2011
ARS Annual report to shareholders Mar 14, 2025 Dec 31, 2024
DEFA14A Additional proxy material Mar 14, 2025 —
DEF 14A Proxy statement Mar 14, 2025 Apr 24, 2025
PRE 14A Preliminary proxy statement Mar 4, 2025 Apr 24, 2025
8-K Current report
Officer or director change
Feb 24, 2025 Feb 18, 2025
8-K Current report
Material agreement, New debt, Other events
Feb 21, 2025 Feb 18, 2025
8-K Current report
Material agreement, Agreement ended, New debt
Feb 20, 2025 Feb 20, 2025
424B5 Prospectus supplement Feb 20, 2025 —
FWP Free writing prospectus Feb 19, 2025 —
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
4 Insider transaction Feb 18, 2025 Feb 13, 2025
8-K Current report
Other events
Feb 18, 2025 Feb 18, 2025
424B3 Prospectus Feb 18, 2025 —
144 Notice of proposed sale Feb 14, 2025 —
10-K Annual report Feb 14, 2025 Dec 31, 2024
4 Insider transaction Feb 11, 2025 Feb 7, 2025
144 Notice of proposed sale Feb 11, 2025 —
4 Insider transaction Feb 5, 2025 Feb 3, 2025
144 Notice of proposed sale Jan 31, 2025 —
4 Insider transaction Jan 30, 2025 Jan 28, 2025
4 Insider transaction Jan 30, 2025 Jan 28, 2025
4 Insider transaction Jan 30, 2025 Jan 28, 2025
4 Insider transaction Jan 30, 2025 Jan 28, 2025
4 Insider transaction Jan 30, 2025 Jan 28, 2025
4 Insider transaction Jan 30, 2025 Jan 28, 2025
4 Insider transaction Jan 30, 2025 Jan 28, 2025
4 Insider transaction Jan 30, 2025 Jan 28, 2025
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jan 24, 2025 Jan 24, 2025
4 Insider transaction Nov 18, 2024 Nov 14, 2024
4 Insider transaction Nov 18, 2024 May 15, 2024
4 Insider transaction Nov 14, 2024 Nov 12, 2024
4 Insider transaction Nov 14, 2024 Nov 12, 2024
144 Notice of proposed sale Nov 14, 2024 —
144 Notice of proposed sale Nov 14, 2024 —
144 Notice of proposed sale Nov 14, 2024 —
4 Insider transaction Nov 13, 2024 Nov 11, 2024
4 Insider transaction Nov 1, 2024 Oct 30, 2024
10-Q Quarterly report Oct 31, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Oct 25, 2024 Oct 25, 2024
4 Insider transaction Sep 12, 2024 Sep 10, 2024
144 Notice of proposed sale Sep 12, 2024 —
4 Insider transaction Aug 12, 2024 Aug 8, 2024
8-K Current report
Material agreement, New debt
Aug 12, 2024 Aug 12, 2024
424B5 Prospectus supplement Aug 9, 2024 —
4 Insider transaction Aug 8, 2024 Aug 6, 2024
8-K Current report
Other events
Aug 8, 2024 Aug 7, 2024
FWP Free writing prospectus Aug 8, 2024 —
4 Insider transaction Aug 7, 2024 Aug 5, 2024
424B3 Prospectus Aug 7, 2024 —
4 Insider transaction Aug 2, 2024 Jul 31, 2024
4 Insider transaction Jul 31, 2024 Jul 29, 2024
4 Insider transaction Jul 31, 2024 Jul 29, 2024
144 Notice of proposed sale Jul 31, 2024 —
4 Insider transaction Jul 29, 2024 Jul 25, 2024
4 Insider transaction Jul 29, 2024 Jul 25, 2024
10-Q Quarterly report Jul 29, 2024 Jun 30, 2024
144 Notice of proposed sale Jul 29, 2024 —
144 Notice of proposed sale Jul 29, 2024 —
144 Notice of proposed sale Jul 29, 2024 —
144 Notice of proposed sale Jul 25, 2024 —
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jul 23, 2024 Jul 23, 2024
4 Insider transaction May 20, 2024 May 16, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
144 Notice of proposed sale May 16, 2024 —
144 Notice of proposed sale May 15, 2024 —
4 Insider transaction May 13, 2024 May 9, 2024
4 Insider transaction May 13, 2024 May 9, 2024
4 Insider transaction May 13, 2024 May 9, 2024
144 Notice of proposed sale May 9, 2024 —
144 Notice of proposed sale May 9, 2024 —
4 Insider transaction May 8, 2024 May 6, 2024
144 Notice of proposed sale May 7, 2024 —
4 Insider transaction May 6, 2024 May 2, 2024
144 Notice of proposed sale May 6, 2024 —
10-Q Quarterly report May 2, 2024 Mar 31, 2024
144 Notice of proposed sale May 2, 2024 —
4 Insider transaction May 1, 2024 Apr 29, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-General Medical & Surgical Hospitals, NEC (SIC 8062)
Listed as
HCA (NYSE)
Fiscal year ends
December 31
Headquarters
Nashville, TN
SEC filer status
Large accelerated filer
SEC CIK
860730
Former names
HCA Holdings, Inc. (until May 5, 2017); HCA INC/TN (until Nov 24, 2010); HCA THE HEALTHCARE CO (until May 21, 2001); HCA-THE HEALTHCARE CO (until Feb 14, 2001); COLUMBIA HCA HEALTHCARE CORP (until May 19, 2000)

Other Services-General Medical & Surgical Hospitals, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.